Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/15/2026

1. SPY
2. PYPL
3. JPM
4. AMZN
5. MSFT
6. GS
7. USO
8. GOOGL
9. BAC
10. IBM

Go back to Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Capricor Therapeutics (CAPR) Tops Q3 EPS by 5c

November 14, 2023 4:08 PM EST

Capricor Therapeutics (NASDAQ: CAPR) reported Q3 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6.19 million versus the consensus estimate of $3.15 million.

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More